Compare CDNA & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDNA | VRTS |
|---|---|---|
| Founded | 1998 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 968.0M |
| IPO Year | 2007 | 1995 |
| Metric | CDNA | VRTS |
|---|---|---|
| Price | $21.60 | $144.11 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $28.00 | ★ $158.00 |
| AVG Volume (30 Days) | ★ 652.5K | 73.4K |
| Earning Date | 04-28-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 6.68% |
| EPS Growth | N/A | ★ 18.24 |
| EPS | 0.05 | ★ 1.05 |
| Revenue | ★ $48,324,000.00 | N/A |
| Revenue This Year | $16.01 | N/A |
| Revenue Next Year | $11.31 | $1.66 |
| P/E Ratio | $429.80 | ★ $134.82 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $10.96 | $121.61 |
| 52 Week High | $23.24 | $214.88 |
| Indicator | CDNA | VRTS |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 55.56 |
| Support Level | $15.80 | $135.82 |
| Resistance Level | $22.89 | $147.15 |
| Average True Range (ATR) | 1.00 | 5.32 |
| MACD | -0.06 | -0.18 |
| Stochastic Oscillator | 76.54 | 79.01 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.